Fatal cytomegalovirus disease in a high-risk renal transplant recipient

详细信息    查看全文

• 作者：Frank Tenney and Abdullah Sakarcan
• 关键词：Keywords  ; CMV ; Pediatrics ; Daclizumab ; Tacrolimus ; Kidney ; Transplantation ; Mycophenolate ; Immunosuppression
• 刊名：Pediatric Nephrology
• 出版年：2001
• 出版时间：January 2001
• 年：2001
• 卷：16
• 期：1
• 页码：8-10
• 全文大小：62 KB

文摘

The incidence of CMV infection in pediatric renal transplant recipients has increased as immunosuppression levels deepen following the use of newer immunosuppressive agents. It has been thought that 3–5 months of anti-CMV prophylaxis offers sufficient protection for these patients. We present a case of late-onset fatal CMV disease in a pediatric renal transplant recipient who received prolonged anti-CMV prophylaxis while on ”quadruple” immunosuppression with daclizumab, mycophenolate, tacrolimus, and prednisone. Our case has prompted us to reassess CMV surveillance, prophylaxis, and immunosuppression levels in our pediatric renal transplant patients.